New bacterial mRNA vaccine technology shows promise in fighting plague, and could help address the global threat of ...

A soil-dwelling microbe has shown a surprising ability to trap carbon dioxide and turn it into rock. Scientists have ...

First patient dosing in Company’s Phase 2b trial marks pivotal milestone in phage therapy development program targeting ...

In the ongoing battle against antibiotic-resistant bacteria, MSU researchers have made a discovery that could reshape how we ...

A recent review by researchers at Philadelphia College of Osteopathic Medicine (PCOM) shows Chlamydia pneumoniae (Cpn) and ...

Scratching an itchy rash really does make it worse, according to new research. But it can also provide defence against ...

MIT researchers identified compounds that can fight off viral infection by activating a defense pathway inside host cells. These compounds could be used as antiviral drugs that work against not just ...

Although rare, an untreated bacterial sinus infection can cause severe complications. Learn more here.

The rapid lateral flow assay from Lumos Diagnostics distinguishes bacterial and nonbacterial respiratory infections using a drop of blood.

The rapid test newcomer offers fast, reliable respiratory diagnostics — a timely addition to the American healthcare toolkit.

BiomX has dosed the first subject in the randomised Phase IIb trial of the company’s fixed multi-phage therapy, BX004, to ...

Lumos Diagnostics shares today soared by more than 150pc after the company unveiled a US distribution deal worth as much as ...